Shares of Brightstar Lottery surged 10.3% to $11.15 after the company posted second-quarter results that convinced investors to look past a notable revenue shortfall and focus on what's coming next: a turning point in cash generation now that the company's costliest obligation is behind it.

Profit Blew Past a Low Bar, but Revenue Keeps Shrinking

BRSL reported earnings of $0.11 per share, beating estimates of $0.02 by $0.09. Yet revenue came in at $584 million, missing Wall Street's $604.8 million estimate by roughly $21 million.

Q2 revenue fell from $631 million a year ago, mainly due to higher amortization of Italian Lotto license fees and the U.K. contract transition. In plain terms, the top line is declining, but management is cutting costs fast enough to widen the gap between what Brightstar earns and what it spends — and that is what the market is rewarding.

The $1.7 Billion Payment Is Done — Cash Flow Can Finally Breathe

CEO Vince Sadusky declared that "with the final Italy Lotto license payment behind us, revenue, profit, and cash flow are poised to inflect."

Brightstar's share of the final Lotto license payment was $1.03 billion, part of a total $1.67 billion installment made in April 2026.

Management highlighted a path to over $400 million in annual free cash flow once the current heavy-spending period ends after 2028. For a stock trading near $11, that would represent enormous cash yield — if the company delivers.

Cost Cuts and a ~9% Dividend Yield Anchor the Bull Case

Brightstar raised its savings target to $100 million from $80 million, with $70 million expected by year-end 2026 and the rest through 2028. The stock carries a nearly 9% trailing dividend yield , and year-to-date shareholder returns total $140 million — $85 million in dividends plus $55 million in buybacks.

Net debt leverage sits at 3.24x with $1.7 billion in liquidity.

Analysts See Big Upside — If Execution Holds

Across 14 analysts, the average 12-month price target is $16.17 — implying roughly 43% upside from current levels. But that target has been trimmed 20.7% in the past three months , reflecting real skepticism about whether shrinking revenue can support a recovery. The quarter proved BRSL can protect margins; the open question is whether it can grow again.